Cargando…
History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
Buprenorphine-based medications were first approved by the United States Food and Drug Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) as the condition is presently known. This regulatory milestone was the outcome of 36 years of research and development, w...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040330/ https://www.ncbi.nlm.nih.gov/pubmed/36994370 http://dx.doi.org/10.1016/j.dadr.2023.100133 |